Systematic review and meta-analysis to estimate potential recruitment to dementia intervention studies

International Journal of Geriatric Psychiatry

Volumn 29, Issue 5, 2014, Pages 515-525

  Cooper, Claudia ^a   Ketley, Daniel ^a   Livingston, Gill ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

consumer participation; inequalities; patient selection

Indexed keywords

DONEPEZIL; CHOLINESTERASE INHIBITOR;

ALZHEIMER DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; EDUCATION; GENDER; HOME MENTAL HEALTH CARE; HUMAN; INTERVENTION STUDY; LONGITUDINAL STUDY; META ANALYSIS; MINI MENTAL STATE EXAMINATION; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; UNITED KINGDOM; VALIDITY; FEMALE; MALE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; STATISTICS AND NUMERICAL DATA;

CHOLINESTERASE INHIBITORS; DEMENTIA; ELIGIBILITY DETERMINATION; FEMALE; GREAT BRITAIN; HUMANS; MALE; PATIENT PARTICIPATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84897982750     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4034     Document Type: Review

References (26)

1. Albert SM, Sano M, Marder K, et al,. 1997. Participation in clinical trials and long-term outcomes in alzheimer's disease. Neurol 49 (1): 38-43.
2. Almici M, Sartori S, Lombardi F, et al,. 2012. Too many hidden patients. The exclusion of individuals with alzheimer's disease from alzheimer's disease pharmacological clinical trials. J Am Geriatr Soc 60 (8): 1596-1597.
3. Anand R, Hartman R, Sohn H, Danyluk J, Graham SM,. 2003. Impact of study design and patient population on outcomes from cholinesterase inhibitor trials. Am J Geriatr Psychiatry 11 (2): 160-168.
4. Andersen F, Engstad TA, Straume B, et al,. 2010. Recruitment methods in alzheimer's disease research: general practice versus population based screening by mail. BMC Med Res Methodol 10: 35.
5. Austrom MG, Bachman J, Altmeyer L, Gao S, Farlow, M., 2010. A collaborative Alzheimer disease research exchange using a community-based helpline as a recruitment tool. Alzheimer Dis Assoc Disord 24: Suppl, S49-S53.
6. Boyle MH,. 1998. Guidelines for evaluating prevalence studies. Evid Based Ment Health 1 (2): 37-39.
7. Cameron D., 2013. The Prime Minister's Challenge on Dementia Delivering Major Improvements in Dementia Care and Research by 2015: Annual Report of Progress. TSO: London.
8. Carr SA, Davis R, Spencer D, et al,. 2010. Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in alzheimer disease clinical trials. Alzheimer Dis Assoc Disord 24 (2): 165-170.
9. Cohen-Mansfield J., 2002. Recruitment rates in gerontological research: the situation for drug trials in dementia may be worse than previously reported. Alzheimer Dis Assoc Disord 16 (4): 279-282.
10. Comas-Herrera A, Wittenberg R, Pickard L, Knapp M., 2007. Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatr 22 (10): 1037-1045.
11. Cooper C, Tandy AR, Balamurali TBS, Livingston G., 2010. A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research. Am J Geriatr Psychiatr 18 (3): 193-203.
12. Ferri CP, Prince M, Brayne C, et al,. 2005. Global prevalence of dementia a delphi consensus study. Lancet 366 (9503): 2112-2117.
13. Gallagher-Thompson D, Rabinowitz Y, Tang PC, et al,. 2006. Recruiting chinese americans for dementia caregiver intervention research: suggestions for success. Am J Geriatr Psychiatr 14 (8): 676-683.
14. Gallagher-Thompson D, Singer LS, Depp C, Mausbach BT, et al,. 2004. Effective recruitment strategies for latino and caucasian dementia family caregivers in intervention research. Am J Geriatr Psychiatr 12 (5): 484-490.
15. Gill SS, Bronskill SE, Mamdani M, et al,. 2004. Representation of patients with dementia in clinical trials of donepezil. Can J Clin Pharmacol 11 (2): e274-e285.
16. Grill JD, Monsell S, Karlawish J., 2012. Are patients whose study partners are spouses more likely to be eligible for alzheimer's disease clinical trials? Dement Geriatr Cogn Disord 33 (5): 334-340.
17. Harbord RM, Egge M, Sterne JAC,. 2006. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25 (20): 3443-3457.
18. Knapp M, Prince M, Albanese E, Banerjee S, Dhanasiri S, et al,. 2007. Dementia UK (A Report to the Alzheimer's Society on the Prevalence and Economic Cost of Dementia in the UK Produced by King's College London and London School of Economics). Alzheimer's Society: London.
19. Lazovski J, Losso M, Krohmal B, et al,. 2009. Benefits and burdens of participation in a longitudinal clinical trial. J Empir Res Hum Res Ethics 4 (3): 89-97.
20. Mapstone J, Elbourne D, Roberts I., 2007. Strategies to improve recruitment to research studies. Cochrane Database Syst Rev (2).
21. Olin JT, Pawluczyk S, Kaufman G., 1997. A comparative analysis of Spanish and english speaking alzheimer's disease patients: eligibility and interest in clinical drugs trials. J Clin Geropsychol 3: 183-190.
22. Raman R, Thomas RG, Weiner MW, et al,. 2009. MRI substudy participation in alzheimer disease (AD) clinical trials baseline comparability of a substudy sample to entire study population. Alzheimer Dis Assoc Disord 23 (4): 333-336.
23. Schneider LS, Olin JT, Lyness SA, Chui HC,. 1997. Eligibility of alzheimer's disease clinic patients for clinical trials. J Am Geriatr Soc 45 (8): 923-928.
24. Treves TA, Verchovsky R, Klimovitsky S, Korczyn AD,. 2000. Recruitment rate to drug trials for dementia of the alzheimer type. Alzheimer Dis Assoc Disord, 14 (4): 209-211.
25. Uybico SJ, Pavel S, Gross CP,. 2007. Recruiting vulnerable populations into research: A systematic review of recruitment interventions. J Gen Intern Med 22 (6): 852-863.
26. World Health Organisation. 2012. Dementia a Public Health Priority. World Health Organisation: UK